A retrospective analysis of electronic health records reports an association between taking glucosamine—a commonly used supplement for joint pain—and worse outcomes in people with Alzheimer’s disease and those at risk for dementia. The study finds that individuals with Alzheimer’s who took glucosamine have a higher likelihood of death within five years than those who did not, with figures reported as about 25% higher risk. Other coverage also describes the supplement as being linked to faster progression, including worsening from mild cognitive impairment to Alzheimer’s, though details vary by framing across outlets. ScienceDaily reports that the researchers also identified biological “clues” that may help explain the observed pattern. The reports emphasize that the findings come from observational data rather than randomized clinical trials, meaning they cannot prove that glucosamine directly causes faster disease progression. Still, the study raises questions about the safety of glucosamine use for older adults and people with cognitive impairment, with calls for further research to confirm the relationship and clarify mechanisms.
Glucosamine supplement linked to faster Alzheimer’s progression in retrospective study
A retrospective analysis of electronic health records reports an association between taking glucosamine—a commonly used supplement for joint pain—and worse outcomes in people with Alzheimer’s disease...
- Glucosamine, a widely used joint supplement, is associated with worse dementia outcomes in the study.
- Among people with Alzheimer’s, glucosamine users show about a 25% higher likelihood of death within five years than non-users.
- The study analyzes electronic health record data, making the evidence observational.
- Some reporting indicates an association with faster progression to Alzheimer’s, including from mild cognitive impairment.
- Researchers report possible biological clues, but results do not establish direct causation.
People with Alzheimer’s disease who took glucosamine were 25% more likely to die within five years than those who didn’t
2 months agoPopular joint supplement glucosamine may speed Alzheimer's progression, raising urgent questions for millions.
2 months agoPeople with Alzheimer’s disease who took the common supplement glucosamine were 25% more likely to die within five years than those who didn’t
2 months agoA major study suggests glucosamine, a popular supplement for joint pain, could be linked to faster progression from mild cognitive impairment to Alzheimer’s disease. Researchers found a 25% higher likelihood of developing dementia among glucosamine users and uncovered biological clues that may explain why.
2 months ago(MedPage Today) -- Glucosamine -- a popular supplement used for joint pain -- was associated with faster progression to Alzheimer's disease and worse survival among Alzheimer's patients, a retrospective study of electronic health records suggested...
2 months ago
Oyo Nyimba, Uganda’s Tooro king crowned at three, dies at 34
Oyo Nyimba, the Ugandan traditional king of the Tooro kingdom, dies at the age of 34. Multiple outlets report that his d...
Procam launches “HDOR – 100 Days of Running” to build long-term movement habits
Procam launches “HDOR – 100 Days of Running,” an initiative framed around completing 100 days of running to encourage re...
Cholesterol-lowering drug trial finds reduced cardiovascular events in older independent living
A world-first clinical trial reports that a common cholesterol-lowering medication significantly reduces the risk of maj...